Wellola offers a highly adaptable patient-facing communications platform. It connects to hospital and GP systems alike, giving patients access to their healthcare information – both clinical and administrative, offering huge cost savings on paper, post and no shows whilst supporting preventative and community based care

1. Adaptable Patient-Facing Communication Platform for Healthcare Providers

2. A Dublin-based digital health IT firm
established in 2016 with proven market
traction & established recurring revenue
streams.
A community focused healthcare system
where only the sickest of the sick are
hospitalised.
An innovative communications platform that
connects Hospital & GP systems to patients,
enabling remote treatment & sharing of
healthcare information in one interface.
750 organisations across Ireland, UK & Italy
including the National Health Service (NHS) in
the UK & the Health Service Executive (HSE) in
Ireland.
Wellola - Who We Are

3. The Problems We Solve
Healthcare Providers throughout Europe are struggling to meet modern, consumer-led healthcare demands.
Outdated methods of patient communication, appointment management and an overreliance on physical
care delivery create systemic inefficiencies for Providers. This results in:
• Non Attendance Costs: In 2019, the NHS (UK) alone lost c.€1.16 Billion due to
patient appointment no-shows.
• High Communication Costs: On average the NHS (UK) spends €120m on post
p.a.
• In-Patient Care Costs: Caring for patients in hospital costs an average of €470
more per day compared to remote care (UK).
• Poor Care Management: Reliance on physical patient treatment reduces ability
of providers to monitor patients and promote disease prevention.
• Poor Communication & Information Sharing on healthcare plans results in low
patient engagement & awareness.

4. The Solution: Wellola’s Adaptable Patient-Facing Platform
Wellola’s innovative patient communication platform provides Healthcare Providers with a single digital
communication & remote care solution to cut costs & optimise healthcare delivery for their patients.
 Digital appointment management capability: results in fewer patient
no-shows and eliminates costs associated with non attendance.
 Digitisation of communication via messaging and forms: results in
lower postage costs & higher quality patient data capture.
 Remote care delivery capability via video consultation: reduces care
delivery costs & reliance on unnecessary physical attendance.
 Interactive patient-facing communication: enables physicians to
monitor and manage patients before they deteriorate.
 Digitised sharing of medical material resources: promotes patient
education and disease prevention.

5. How It Works
5
Patient registers to use the
Wellola portal on the hospital/
clinic’s site & downloads app.
The patient can view their
medical records, manage
appointments & more.
Private hospital patients can
receive invoices & pay their
bills.
Online treatment
provided via Wellola’s
video tool if required.
Family members can have access
to the portal to support care
management of vulnerable
relatives.
The patient can receive educational
material from the healthcare provider
(e.g. how to take your inhaler).
The patient can track & share their
physical & mental health symptoms with
their healthcare provider via the
symptom tracker.
Linked devices can feed data to
clinical teams via the portal (blood
pressure, heart rate etc.).
Patients are supported to self-
manage, are attended to before
deterioration & cared for
remotely
Wellola integrates its platform
with the hospital/clinic’s
Electronic Patient Record (EPR)
system.

6. Fully Interoperable - FHIR APIs
Core Communication Tools
Video Capability
Option To White-Label
ISO27001, DCB0129 Certified
Hosted AWS EU/ UK &
Managed by Deloitte
Our Uniquely Adaptable Product
Allows us to read data from, &
share data with, other software
systems.
Includes Forms, Messaging,
Appointments, Symptom
Tracking, Education & Device
Linking.
Proprietary WebRTC solution,
fully managed & scalable. Enables
group & 1:1 chat, white-board,
screen-sharing & more.
Allows our customers to offer
their patients a “digital front
door” under their own brand.
These certifications are
essential for Wellola to service
healthcare buyers.
Flexible offering that allows us to
host in the UK, EU or as required
by the customer.

7. Testimonials
Companyname
.com
Our Customers & Partners
• We deliver a secure patient-facing communications platform for
Governments, Hospitals, Healthcare Systems & Professional Bodies.
• Currently selling in 3 Jurisdictions - Ireland, UK & Italy with over
€400K of recurring sales secured to date in 2021.
• Blue Chip Customers include the NHS, HSE & Nutricia Danone.
• Currently integrating with 5 electronic healthcare record systems in
primary & secondary care market in the UK.
• Signed partner of leading EPR software providers including Servelec
(60 NHS Sites), EBO & ThinkBio.
• Approved by NHS Digital to sell via the DFOCVC Framework.
”This will be a key tool in providing
remote care to patients in Ireland”
Martin Curley, Director of the Digital
Transformation & Open Innovation,
HSE
”We are proud to work with
Wellola to deliver this state-of-
the-art technology to our Nutricia
Care Nursing Home partners”
Noel Daly, Services Manager,
Nutricia Danone

8. Global
€60 Million
CAGR 6%
UK
Europe
€8 Billion
CAGR 14%
The Market
Pre-Covid-19 the telehealth industry was predicted to reach €25 Billion by 2021 with a CAGR of 20%.
Components include patient portals, online consultations, video and patient services.
COVID-19 has driven huge
growth in telehealth & remote
care adoption.
Move to remote, community -
based care delivery via Digital
Tools.
Move to preventative,
personalised care models.
Market Drivers
Source: IBIS 2020
€25 Billion+
CAGR 20%

9. The Competitive Landscape
Untethered
Acute & Primary Care
Tethered
Community, Mental Health & Social Care
 Untethered (capable to plug-n-play with any
healthcare software system).
 First Mover Advantage-via Partnerships.
 Underserviced Market.
 Affordable & Attractive Pricing Model (Fixed,
Predictable, no add-ons).

10. Sonia Neary, CEO
• Co-Founder.
• Chartered Physiotherapist- 15
years in public & private
healthcare.
• Project led development from
MVP.
• Current Commercial Lead.
Dr Greg Martin, CMO
• Co-Founder.
• MBA & MPH.
• Editor-in-Chief: Globalization
& Health.
• Experience at WHO, Bill Clinton
Foundation, Cancer Research Fund.
• Voted 5th most influential voice in
healthcare on LinkedIn.
Criostoir O’Codlatain, CTO
• Co-Founder.
• BSc Enterprise Computing.
• Technical Lead.
• Full- stack Developer.
• Experience at IBM & Merrill
Lynch.
Martin Bell, Strategic Advisor
• Experienced Board level CIO in the
NHS.
• Previous Senior Exec at UK’s
largest UK clinical systems
provider.
• Deep NHS, healthcare IT & digital
knowledge.
Our Leadership Team

11. Our Route To Market
• Wellola integrates its product with leading electronic patient record (EPR) software providers (e.g. Servelec).
• The EPR software provider sells their software to their new & existing Healthcare Provider customers (e.g. NHS).
• Our solution can be ‘switched on’ as an ancillary module or service by any of the EPR provider's customers.
• Our once off implementation with the EPR provider and partnership model allows us to scale with ease.
• Recurring Revenue: Wellola & the EPR provider operate under a recurring shared licence model.
Route To Market: Partnership Approach
Professional Services:
One-Off Implementation Fee:
Average €58K.
Annual Recurring Licence:
(as per population serviced)
€110K - €260K p.a.
Pricing Model

12. Year 2021 2022 2023 2024 2025
€ Sales 550,619 3,833,078 9,584,270 14,430,058 19,607,841
€ Gross Profit 129,839 1,688,674 6,303,210 9,923,708 13,876,321
€ EBITDA (72,511) (107,726) 3,628,210 6,489,708 9,854,321
EBITDA (%) -13% -3% 38% 45% 50%
Staff
15 79 91 92 92
Our Projections
*Note Development Costs are capitalised

13. Commercial &
Support Staff
Head of
Commercial
Development
Customer
Success Teams
Project
Management
Teams
Technical Staff: UK
Integration
UK Electronic
Patient Record
Providers
NHS Login
IM1 (GP
Systems)
Expand EU
Localise
Platform
Establish
Business Units
Port/Spa/Ger
EPR
Integrations
The Ask
25%
50%
25%
Wellola is seeking to raise €3m to:
 Recruit commercial & support staff to drive platform development, growth & adoption.
 Recruit technical staff to continue integration and build on traction in the UK market.
 To drive EU expansion into new markets, including Portugal, Spain & Germany.

14. sonia@wellola.com | www.wellola.com |+353 1 298 8132

15. 2019 2020 2021 2022
Established in Ireland in
Sept 2016, Wellola
developed a practice
management tool for
clinics as our initial
product.
Secured early sales, EU,
EI & private funding.
In 2019 we set-up in UK
to allow for contracting
with UK entities.
UK Subsidiary
Our Patient
Communications
Platform gains greater
traction and positive
market fit.
New sales & validation
come from the HSE,
Nutricia Danone, BACP,
& others.
Enterprise Sales
Secured first large
scale enterprise deals,
with recurring
revenue, in the UK.
Early Deals UK
Strategic plan to
increase UK sales
across Secondary &
Private Care & to build
the foundations for
our EU expansion.
Expansion
Appendix: Company Timeline

16. Q3/ Q4 2021
2022
2023
2024
2025
Focus on
underserviced
aspects of the UK
market.
Capitalise on
Opportunity
Increase Customer
Base via Partners.
UK Expansion
Launch following
integration with
technical partners.
Germany
Launch following
integration with
technical partners.
Portugal & Spain
Europe’s most
accessible patient
communications
platform & system.
Long Term Goal
Appendix: Our Commercial Roadmap

17. Q3/ Q4 2021
2022
Q2 2022
Q4 2022
2023
NHS Login offered as
an authentication
mechanism.
User
Authentication
Integrating with
leading EPR solutions
in Primary & Secondary
Care Market.
Integration - 5 EPRs
Internationalise our
platform for multiple
EU markets.
Localisation
Integration with
technical partners in
Germany, Portugal &
Spain.
EU Integration
Virtual Agent, Voice
Enablement, Eye-
Tracking & more.
Advanced
Accessibility
Appendix: Our Technical Roadmap

18. Disclaimer
This Presentation is delivered on behalf of Wellola to a limited number of parties who may be interested in a potential investment in Wellola. The sole purpose of this
Presentation is to assist the recipient in deciding whether to proceed with further discussions with Wellola. This Memorandum does not purport to be all-inclusive or to
contain all the information that a prospective investor may desire about Wellola or its business. This Presentation has been prepared by Wellola for informational purposes
relating to a potential investment only and upon the express understanding that it will be used for only the purposes set forth above. Wellola does not make any express or
implied representation or warranty as to the accuracy or completeness of the information contained herein or made available in connection with any further investigation of
the target. Wellola expressly disclaims any and all liability that may be based on such information, errors therein or omissions therefrom. The recipient shall be entitled to
rely solely on the representations and warranties made to it by Wellola in any final transaction agreement. In furnishing this Presentation, Wellola does not undertake any
obligation to provide the recipient with access to any additional information. This Presentation shall not be deemed an indication of the state of affairs of Wellola nor shall it
constitute an indication that there has been no change in the business or affairs of Wellola since the date hereof. This Presentation contains certain financial projections and
other forward-looking statements prepared by Wellola’s management. The projections and forward-looking statements are based on numerous variables and assumptions
that are inherently uncertain and beyond Wellola’s control. The furnishing of these projections and forward-looking statements should not be regarded as an indication that
Wellola considers them to be predictive of actual future events and should not be relied upon as such. There is a substantial likelihood that the actual results of the target’s
operations will differ materially from the projections or that the information contained in any forward-looking statement will differ materially from actual results and events.
The projections are included herein solely to give interested parties information concerning management’s estimates of the scope of future opportunities based on certain
assumptions.
sonia@wellola.com | www.wellola.com |+353 1 298 8132